Bausch Health Companies (TSE:BHC) Shares Up 4.5% - Time to Buy?

Key Points

• Bausch Health Companies Inc. shares increased by 4.5% to C$8.87, although trading volume fell 22% from the average session.
• The company has a market capitalization of C$3.28 billion and a price-to-earnings ratio of 34.12.
• Bausch Health focuses on developing and marketing products in eye health, gastroenterology, and dermatology.

Bausch Health Companies Inc. (TSE:BHC - )'s share price shot up 4.5% during trading on Monday . The company traded as high as C$8.96 and last traded at C$8.87. 291,768 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 375,781 shares. The stock had previously closed at C$8.49.

Bausch Health Companies Trading Up 4.5%

The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of -1,831.94. The business has a fifty day simple moving average of C$9.61 and a 200 day simple moving average of C$8.31. The company has a market cap of C$3.28 billion, a price-to-earnings ratio of 34.12, a P/E/G ratio of 0.21 and a beta of 0.68.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.